176
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the Anterior Segment Parameters of the Patients with Scleroderma

, MD, , MD, , MD ORCID Icon, , MD, , MD, , MD , PhD, , MD & , MD show all
Pages 233-238 | Received 14 May 2015, Accepted 28 Oct 2015, Published online: 30 Jan 2016

REFERENCES

  • Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev. 2003;2(4):181–191.
  • Tailor R, Gupta A, Herrick A, et al. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54(2):292–304.
  • Gilliland BC. Systemic sclerosis (scleroderma) and related disorders. In: Kasper DI, Braunwald E, Fauci AS, et al., eds. Harrison’s Principles of Internal Medicine. 16th edn. New York: McGraw-Hill; 2005:1979–1999.
  • Ambrósio R Jr, Alonso RS, Luz A, et al. Corneal-thickness spatial profile and corneal-volume distribution: tomographic indices to detect keratoconus. J Cataract Refract Surg. 2006;32(11):1851–1859.
  • Hirnschall N, Crnej A, Gangwani V, et al. Effect of fluorescein dye staining of the tear film on Scheimpflug measurements of central corneal thickness. Cornea. 2012;31(1):18–20.
  • Serup J, Serup L. Increased central cornea thickness in localized scleroderma (morphoea). Metab Pediatr Syst Ophthalmol. 1985;8(2–3):11–14.
  • Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh). 1984;62(1):69–74.
  • Emre S, Kaykcoglu OM, Ates H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the Reichert ocular response analyzer. Cornea. 2010;29(6):628–631.
  • Gomes Bde A, Santhiago MR, Kara-Junior N, et al. Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea. 2011;30(10):1125–1128.
  • Palamar M, Karatepe A, Eğrilmez S, et al. Evaluation of cornea and anterior chamber with Pentacam in scleroderma cases. Turk J Ophthalmol. 2011;41:221–224.
  • Robert L, Legeais JM, Robert AM, et al. Corneal collagens. Pathol Biol. 2001;49(4):353–363.
  • Cingü AK, Çınar Y, Türkcü FM, et al. Evaluation of corneal parameters with Scheimpflug imaging in patients with rheumatoid arthritis. Ocul Immunol Inflamm. 2013;21(5):360–365.
  • Sii F, Lee GA, Sanfilippo P, et al. Pellucid marginal degeneration and scleroderma. Clin Exp Optom J Aust Optom Assoc. 2004;87(3):180–184.
  • Horie K, Nishi M, Sawa M, et al. [A case of peripheral corneal ulcer accompanied by progressive systemic sclerosis]. Nippon Ganka Gakkai Zasshi. 1992;96(7):922–929.
  • Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea. 1999;18(4):403–407.
  • Doughty MJ, Zaman ML. Human Corneal Thickness and Its Impact on Intraocular Pressure Measures: A Review and Meta-analysis Approach. Surv Ophthalmol. 2000;44(5):367–408.
  • Marsich MW, Bullimore MA. The repeatability of corneal thickness measures. Cornea. 2000;19(6):792–795.
  • Wickham L, Edmunds B, Murdoch IE. Central corneal thickness: will one measurement suffice? Ophthalmology. 2005;112(2):225–228.
  • Barkana Y, Gerber Y, Elbaz U, et al. Central corneal thickness measurement with the Pentacam Scheimpflug system, optical low-coherence reflectometry pachymeter, and ultrasound pachymetry. J Cataract Refract Surg. 2005;31(9):1729–1735.
  • Rabsilber TM, Khoramnia R, Auffarth GU. Anterior chamber measurements using Pentacam rotating Scheimpflug camera. J Cataract Refract Surg. 2006;32(3):456–459.
  • Amano S, Honda N, Amano Y, et al. Comparison of central corneal thickness measurements by rotating Scheimpflug camera, ultrasonic pachymetry, and scanning-slit corneal topography. Ophthalmology. 2006;113(6):937–941.
  • Lackner B, Schmidinger G, Pieh S, et al. Repeatability and reproducibility of central corneal thickness measurement with Pentacam, Orbscan, and ultrasound. Optom Vis Sci. 2005;82(10):892–899.
  • O’Donnell C, Maldonado-Codina C. Agreement and repeatability of central thickness measurement in normal corneas using ultrasound pachymetry and the OCULUS Pentacam. Cornea. 2005;24(8):920–924.
  • Al-Mezaine HS, Al-Amro SA, Kangave D, et al. Comparison between central corneal thickness measurements by oculus Pentacam and ultrasonic pachymetry. Int Ophthalmol. 2008;28(5):333–338.
  • Fujioka M, Nakamura M, Tatsumi Y, et al. Comparison of Pentacam Scheimpflug camera with ultrasound pachymetry and noncontact specular microscopy in measuring central corneal thickness. Curr Eye Res. 2007;32(2):89–94.
  • Kim W-U, Min S-Y, Cho M-L, et al. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther. 2004;7(1):R71.
  • Hamrah P, Liu Y, Zhang Q, et al. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol. 2003;121(8):1132–1140.
  • Kobayashi Y. Langerhans’ cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology. 1997;90(4):496–501.
  • Ratzinger G, Stoitzner P, Ebner S, et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol. 2002;168(9):4361–4371.
  • Chizzolini C, Parel Y, De Luca C, et al. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Arthritis Rheum. 2003;48(9):2593–2604.
  • Rajashekhar G, Shivanna M, Kompella UB, et al. Role of MMP-9 in the breakdown of barrier integrity of the corneal endothelium in response to TNF-α. Exp Eye Res. 2014;122:77–85.
  • Luo L, Li D-Q, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45(12):4293–4301.
  • Steger B, Speicher L, Philipp W, et al. In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. Br J Ophthalmol. 2015;99(2):160–165.
  • Machetta F, Fea AM, Actis AG, et al. In Vivo Confocal Microscopic Evaluation of Corneal Langerhans Cells in Dry Eye Patients. Open Ophthalmol J. 2014;8:51–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.